
Quibim
Quibim
Claim
Quibim plans to become the global leader in virtual biopsies, using quantitative imaging biomarkers to unlock complex diseases signals in medical images.Clinicians, researchers and pharmaceutical companies use Quibim Precision®, an ecosystem of radiological medical image analysis applications, to assess every part of the body and in different clinical scenarios, from disease detection to monitoring the efficacy of new treatments.Quibim plans to become the global leader in virtual biopsies, using quantitative imaging biomarkers Show More
Alpha Score
$ 131.05 M
Alpha Score
69.5
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0